Saturated and trans fats and dementia: A systematic review

Neurobiology of Aging

Volumn 35, Issue SUPPL.2, 2014, Pages

  Barnard, Neal D ^a,b   Bunner, Anne E ^b   Agarwal, Ulka ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE   (United States)

Author keywords

Alzheimer's disease; Dementia; Fatty acids; Nutrition; Saturated fat; Trans fatty acids

Indexed keywords

SATURATED FATTY ACID; TRANS FATTY ACID; APOLIPOPROTEIN E4; FAT INTAKE; FATTY ACID;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FAT INTAKE; HUMAN; MENTAL DETERIORATION; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUTRITIONAL HEALTH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; VERBAL MEMORY; CALORIC INTAKE; COGNITIVE DEFECT; FOOD FREQUENCY QUESTIONNAIRE; GENE FREQUENCY; HIGH RISK PATIENT; BIBLIOGRAPHIC DATABASE; INCIDENCE; META ANALYSIS; RISK;

ALZHEIMER DISEASE; DATABASES, BIBLIOGRAPHIC; DEMENTIA; DIETARY FATS; FATTY ACIDS; HUMANS; INCIDENCE; MILD COGNITIVE IMPAIRMENT; RISK; TRANS FATTY ACIDS;

EID: 84903710625     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.030     Document Type: Article

References (40)

1. Bennett A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wilman B., de Faire U., Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
2. Biessels G.J. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006, 5:64-74.
3. Breteler M.M.B., van Swieten J.C., Bots M.L., Grobbee D.E., Claus J.J., van den Hout J.H., van Harskamp F., Tanghe H.L., de Jong P.T., van Gijn J. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994, 44:1246-1252.
4. Cherbuin N., Anstey K.J. The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH through life study. Am. J. Geriatr. Psychiatry 2012, 20:635-639.
5. Collins R., Armitage J., Parish S., Sleight P., Peto R. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 9326:7-22. Heart Protection Study Collaborative Group.
6. Cramer C., Haan M.N., Galea S., Langa K.M., Kalbfleisch J.D. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008, 71:344-350.
7. Devore E.E., Grodstein F., van Rooij F.J., Hofman A., Stampfer M.J., Witteman J.C., Breteler M.M. Dietary antioxidants and long-term risk of dementia. Arch. Neurol. 2010, 67:819-825.
8. Engelhart M.J., Geerlings M.I., Ruitenberg A. Diet and risk of dementia: does fat matter? the Rotterdam Study. Neurology 2002, 59:1915-1921.
9. Englehart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 28:3223-3229.
10. Eskelinen M.H., Ngandu T., Helkala E.L., Tuomilehto J., Nissinen A., Soininen H., Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int. J. Geriatr. Psychiatr 2008, 23:741-747.
11. Haag M., Dippenaar N.G. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med. Sci. Monit. 2005, 11:RA359-RA367.
12. Haag M.D.M., Hofman A., Koudstall P.J., Stricker B.H.C., Breteler M.M.B. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J.Neurol. Neurosurg. Psychiatry 2009, 80:13-17.
13. Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80:1778-1783.
14. Jack C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52:1397-1403.
15. Kalmijn S., Launer L.J., Ott A., Witteman J.C.M., Hofman A., Breteler M.M.B. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 1997, 42:776-782.
16. Kuo Y.M., Emmerling M.R., Bisgaier C.L., Essenburg A.D., Lampert H.C., Drumm D., Roher A.E. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain Aβ levels. Biochem. Biophys. Res. Comm. 1998, 252:711-715.
17. Laitinen M.H., Ngandu T., Rovio S., Helkala E.L., Uusitalo U., Viitanen M., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement. Geriatr. Cogn. Disord. 2006, 22:99-107.
18. Loktionov A., Scollen S., McKeown N., Bingham S. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E (4-carrying free-living individuals. Br. J. Nutr. 2000, 84:885-890.
19. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 2002, 59:1258-1263.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
21. Morris M.C., Evans E.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Schneider J., Wilson R.S. Dietary fats and the risk of incident Alzheimer's disease. Arch. Neurol. 2003, 60:194-200.
22. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Wilson R.S. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004, 62:1573-1579.
23. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., Scherr P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr. 2005, 81:508-514.
24. Naqvi A.Z., Harty B., Mukamal K.J., Stoddard A.M., Vitolins M., Dunn J.E. Monounsaturated, trans, and saturated fatty acids and cognitive decline in women. J.Am. Geriatr. Soc. 2011, 59:837-843.
25. Ohara T., Doi Y., Ninomiya T. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 2011, 77:1126-1134.
26. Okereke O.I., Rosner B.A., Kim D.H., Kang J.H., Cook N.R., Manson J.E., Buring J.E., Willett W.C., Grodstein F. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann. Neurol. 2012, 72:124-134.
27. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
28. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J.Intern. Med. 2004, 256:183-194.
29. Petersen R.C. Mild cognitive impairment. N.Engl. J. Med. 2011, 364:2227-2234.
30. Puglielli L., et al. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell Biol. 2001, 3:905-912.
31. Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci 2003, 6:345-351.
32. Roberts R.O., Roberts L.A., Geda Y.E., Cha R.H., Pankratz V.S., O'Connor H.M., Knopman D.S., Petersen R.C. Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. J.Alzheimer's Dis. 2012, 32:329-339.
33. Rubin J., Berglund L. Apolipoprotein E and diets: a case of gene-nutrient interaction?. Curr. Opin. Lipidol. 2002, 13:25-32.
34. Samuel V.T., Petersen K.F., Shulman G.I. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010, 375:2267-2277.
35. Shepherd J., Blauw G., Murphy M.B. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002, 360:1623-1630.
36. Smith G.E., Petersen R.C., Parisi J.E., et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol. Cogn. 1996, 3:141-147.
37. Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Del Parigi A., Capurso S.A., Argentieri G., Capurso A., Panza F. Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp. Gerontol. 2006, 41:619-627.
38. Solfrizzi V., Colacicco A.M., D'Introno A., Capurso C., Torres F., Rizzo C., Capurso A., Panza F. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging 2006, 27:1694-1704.
39. Solomon A., Kivipelto M., Wolozin B., Zhou J., Whitmer R.A. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr. Cogn. Disord. 2009, 28:75-80.
40. Wong W.B., Lin V.W., Boudreau D., Devine E.B. Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol. Drug Saf. 2013, 22:345-358.